thiazoles has been researched along with Drug Withdrawal Symptoms in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (35.48) | 18.7374 |
| 1990's | 1 (3.23) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 9 (29.03) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Class, MA; Coelho, MA; Lee, KM; Szumlinski, KK | 1 |
| Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH | 1 |
| Berro, LF; Carvalho, RC; Frussa-Filho, R; Fukushiro, DF; Hollais, AW; Kameda, SR; Patti, CL; Zanin, KA | 1 |
| Scheyer, AF; Tseng, KY; Wolf, ME | 1 |
| Adeniji, A; Elgadi, M; Huang, F; Joseph, D; Riesenberg, RR; Schobelock, MJ; Vince, BD; Webster, LR | 1 |
| Alvarez, Jdo N; Carvalho, Rde C; Frussa-Filho, R; Fukushiro, DF; Ribeiro, LT; Ricardo, VP | 1 |
| Bochenski, M; Kotlinska, J | 2 |
| Akiyama, H; Fukuda, S; Kobayashi, T; Nagata, Y; Ohashi, K; Sakamaki, H; Yamashita, T | 1 |
| Celikyurt, IK; Erden, FB; Kayir, H; Ulak, G; Ulusoy, GK; Uzbay, TI | 1 |
| Bochenski, M; Danysz, W; Kotlinska, JH | 1 |
| Ash, P; Craighead, WE; Jacob, MK | 1 |
| BRUCE, DW | 1 |
| BARTHOLOMEW, AA; BRUCE, DW | 1 |
| Li, N; Sorg, BA; Wu, WR | 1 |
| Berger, JE; Martin, H; Rasmussen, K; Seager, MA | 1 |
| Asensio, VJ; Esteban, S; García-Sevilla, JA; Miralles, A; Moranta, D; Sastre-Coll, A | 1 |
| Altinbas, K; Demirkiran, S; Oral, ET | 1 |
| Fujita, K; Okazaki, Y; Tanii, H | 1 |
| Ciccocioppo, R; Cippitelli, A; Cramer, J; Gehlert, DR; Hamdouchi, C; Heilig, M; Hembre, EJ; Hipskind, PA; Lê, AD; Lu, J; McKinzie, D; Morin, M; Song, M; Thorsell, A | 1 |
| Cuffel, BJ; Loebel, AD; Mullins, CD; Naradzay, J; Obeidat, NA | 1 |
| Cai, ZJ; Li, M; Liu, LN; Liu, YH; Zhang, JL; Zheng, JW | 1 |
| Kjolstad, T | 1 |
| Quinn, JT | 1 |
| Rotter, H | 1 |
| Asander, H | 1 |
| Leivonen, P; Stenij, P; Thesleff, CJ | 1 |
| Sattes, H | 1 |
| Glatt, MM | 1 |
| Gastager, H | 1 |
| Frisch, EP; George, HR; Glatt, MM | 1 |
2 trial(s) available for thiazoles and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine-naloxone in subjects receiving stable addiction management therapy.
Topics: Administration, Oral; Adult; Aminoisobutyric Acids; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Drug Interactions; Female; Humans; Leucine; Male; Methadone; Middle Aged; Oligopeptides; Proline; Quinolines; Substance Withdrawal Syndrome; Substance-Related Disorders; Thiazoles; Young Adult | 2015 |
Evaluation of chlormethiazole in treatment for alcohol withdrawal syndrome. Results of a controlled trial.
Topics: Alcoholism; Chlormethiazole; Clinical Trials as Topic; Depression; Female; Humans; Hypertension; Hypnotics and Sedatives; Male; Phenytoin; Substance Withdrawal Syndrome; Thiazoles; Tremor | 1966 |
29 other study(ies) available for thiazoles and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
mGlu5-dependent modulation of anxiety during early withdrawal from binge-drinking in adult and adolescent male mice.
Topics: Age Factors; Animals; Anxiety; Benzamides; Binge Drinking; Dose-Response Relationship, Drug; Ethanol; Male; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Pyrazoles; Pyridines; Receptor, Metabotropic Glutamate 5; Substance Withdrawal Syndrome; Thiazoles | 2018 |
The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
Topics: Acamprosate; Amphetamine; Animals; Anxiety; Bridged Bicyclo Compounds; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Ligands; Male; Memantine; Pyridines; Rats; Receptors, Ionotropic Glutamate; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Taurine; Thiazoles | 2013 |
Effects of acute and long-term typical or atypical neuroleptics on morphine-induced behavioural effects in mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Female; Haloperidol; Mice; Morphine; Motor Activity; Piperazines; Substance Withdrawal Syndrome; Thiazoles | 2014 |
A protein synthesis-dependent mechanism sustains calcium-permeable AMPA receptor transmission in nucleus accumbens synapses during withdrawal from cocaine self-administration.
Topics: Animals; Benzoates; Calcium; Cocaine-Related Disorders; Cycloheximide; Excitatory Amino Acid Antagonists; Glycine; Male; Methoxyhydroxyphenylglycol; Nucleus Accumbens; Patch-Clamp Techniques; Protein Biosynthesis; Protein Synthesis Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Self Administration; Substance Withdrawal Syndrome; Synapses; Synaptic Transmission; Thiazoles; Ventral Tegmental Area | 2014 |
Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Haloperidol; Humans; Male; Mice; Motor Activity; Piperazines; Schizophrenia; Substance Withdrawal Syndrome; Thiazoles | 2008 |
The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
Topics: Acamprosate; Alcohol Deterrents; Animals; Anxiety; Behavior, Animal; Central Nervous System Depressants; Ethanol; Excitatory Amino Acid Antagonists; Male; Memantine; Pyridines; Quinolines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Taurine; Thiazoles | 2008 |
Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase.
Topics: Aged; Antineoplastic Agents; Benzamides; Dasatinib; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Substance Withdrawal Syndrome; Thiazoles | 2010 |
Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.
Topics: Alcoholism; Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Central Nervous System Depressants; Comorbidity; Dibenzothiazepines; Ethanol; Humans; Hyperkinesis; Male; Motor Activity; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Rats; Rats, Wistar; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Thiazoles; Time Factors | 2011 |
The role of group I mGlu receptors in the expression of ethanol-induced conditioned place preference and ethanol withdrawal seizures in rats.
Topics: Animals; Conditioning, Psychological; Epilepsy, Reflex; Ethanol; Male; Motor Activity; Pyridines; Quinolines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Reproducibility of Results; Seizures; Spatial Behavior; Substance Withdrawal Syndrome; Thiazoles | 2011 |
Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone.
Topics: Depressive Disorder; Female; Hallucinations; Humans; Piperazines; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Thiazoles | 2012 |
AMIPHENAZOLE IN THE TREATMENT OF MORPHINE AND OPIUM ADDICTION.
Topics: Humans; Morphine; Morphine Dependence; Opium; Substance Withdrawal Syndrome; Substance-Related Disorders; Thiazoles | 1964 |
TWO CASES OF ADDICTION TO HEROIN BY SMOKING.
Topics: Heroin; Humans; Morphine; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Thiazoles | 1964 |
Prolonged effects of repeated cocaine on medial prefrontal cortex dopamine response to cocaine and a stressful predatory odor challenge in rats.
Topics: Animals; Chromatography, High Pressure Liquid; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Extracellular Fluid; Microdialysis; Odorants; Prefrontal Cortex; Rats; Stress, Psychological; Substance Withdrawal Syndrome; Thiazoles; Time Factors | 2003 |
The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats.
Topics: Animals; Locus Coeruleus; Male; Morphine; Neurons; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Thiazoles | 2005 |
High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Topics: Animals; Benzofurans; Binding, Competitive; Brain; Carbolines; Cerebral Cortex; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Harmine; Hippocampus; Imidazoles; Imidazoline Receptors; Liver; Male; Monoamine Oxidase; Morphine; Morphine Dependence; Naloxone; Norepinephrine; Picolinic Acids; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Drug; Substance Withdrawal Syndrome; Thiazoles; Tritium; Tyrosine 3-Monooxygenase | 2005 |
Sudden akathisia after a ziprasidone dose reduction.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Piperazines; Substance Withdrawal Syndrome; Thiazoles | 2006 |
Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
Topics: Adult; Antipsychotic Agents; Cholinergic Antagonists; Drug Therapy, Combination; Humans; Indoles; Isoindoles; Male; Neuroleptic Malignant Syndrome; Schizophrenia, Paranoid; Substance Withdrawal Syndrome; Thiazoles | 2006 |
Comparison of the effects of mGluR1 and mGluR5 antagonists on the expression of behavioral sensitization to the locomotor effect of morphine and the morphine withdrawal jumping in mice.
Topics: Animals; Male; Mice; Morphine; Motor Activity; Pyridines; Quinolines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Thiazoles | 2007 |
3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism.
Topics: Administration, Oral; Alcohol Drinking; Alcoholism; Amphibian Proteins; Animals; Anxiety; Behavior, Animal; Brain; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Male; Peptide Hormones; Peptides; Pituitary Gland; Pyridazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Self Administration; Stress, Physiological; Substance Withdrawal Syndrome; Thiazoles | 2007 |
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Readmission; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risk Factors; Risperidone; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Sensitivity and Specificity; Substance Withdrawal Syndrome; Survival Rate; Thiazoles | 2008 |
[Experimental study on the principal effects and dependence potential of thiofentanil].
Topics: Analgesics, Opioid; Animals; Dogs; Female; Immobilization; Macaca mulatta; Male; Mice; Pain; Piperidines; Rabbits; Rats; Sensory Thresholds; Substance Withdrawal Syndrome; Substance-Related Disorders; Thiazoles | 1991 |
Experience with chlormethiazole.
Topics: Chlordiazepoxide; Chlormethiazole; Humans; Hypnotics and Sedatives; Male; Psychoses, Alcoholic; Substance Withdrawal Syndrome; Thiazoles | 1966 |
Oral and intravenous chlormethiazole therapy in the alcoholic withdrawal phase.
Topics: Alcoholism; Chlormethiazole; Humans; Hypnotics and Sedatives; Male; Substance Withdrawal Syndrome; Thiazoles | 1966 |
Chlormethiazole in the treatment of alcoholic out-patients.
Topics: Adolescent; Adult; Aged; Alcoholism; Ambulatory Care; Chlormethiazole; Female; Home Care Services; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychoses, Alcoholic; Substance Withdrawal Syndrome; Thiazoles | 1966 |
Ambulatory treatment of alcoholic patients with chlormethiazole.
Topics: Adult; Alcoholism; Ambulatory Care; Chlormethiazole; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Outpatient Clinics, Hospital; Substance Withdrawal Syndrome; Thiazoles | 1966 |
Experience with three drugs in ambulatory treatment of alcohol patients.
Topics: Alcoholism; Ambulatory Care; Chlormethiazole; Finland; Humans; Hypnotics and Sedatives; Meprobamate; Promazine; Promethazine; Substance Withdrawal Syndrome; Thiazoles; Vitamin B Complex | 1966 |
Chlormethiazole treatment of abstinence symptoms after drug withdrawal. Preliminary reports. I.
Topics: Alcoholism; Chlormethiazole; Humans; Hypnotics and Sedatives; Opium; Phenacetin; Substance Withdrawal Syndrome; Substance-Related Disorders; Thiazoles | 1966 |
Chlormethiazole treatment of abstinence symptoms after drug withdrawal. Preliminary reports. II.
Topics: Adult; Cocaine; Female; Heroin; Humans; Hypnotics and Sedatives; Male; Meperidine; Substance Withdrawal Syndrome; Substance-Related Disorders; Thiazoles | 1966 |
Chlormethiazole treatment of abstinence symptoms after drug withdrawal. Preliminary reports. 3.
Topics: Alcoholism; Barbiturates; Chlormethiazole; Humans; Hypnotics and Sedatives; Male; Meprobamate; Substance Withdrawal Syndrome; Substance-Related Disorders; Thiazoles; Thioridazine | 1966 |